pharmatechoutlook
6 TECH OUTLOOKJanuary 2017Pharma and life sciences industry is in a state of flex. The introduction of far-reaching Patient Protection and Affordable Care Act (PPACA) in the U.S. and similar regulations across globe is not only changing the regulatory framework of the industry, but also impacting the bottom line for the players involved. As a result, the industry is increasingly opting for cloud, mobility, and social media solutions to rationalize internal costs, and facilitate integration of information and processes.The new paradigm is not only leading to a data deluge--from clinical trials, hospital records, marketing, claims, and patient demographic and characteristics--but also driving the pharma companies towards data-driven decision making. This is where analytics solutions are driving the wheel for the industry--helping organizations extract additional value in a constantly changing and challenging market, and gain competitive advantage. The application of pharma analytics in an organization ranges from the basic reporting and internal dashboard creation, high-end predictive and prescriptive analytics, to regulatory compliance reporting, marketing support, and service enablement. But, the pharma analytics market is not without its own set of challenges surrounding poor data integration, lack of investment in talent and technology, and limited stakeholder alignment.Operationalizing analytics in pharma and life sciences requires a balanced approach across people, processes, and technology. The market is replete with solution providers who promise to bring such a balance to the table. In such a scenario, our goal with this special edition is to help organizations meet best-of-breed pharma analytics solution providers who can sketch successful analytics roadmap for pharma companies. This edition also blends thought-leadership from subject matter experts with real stories on what selected vendors are doing for their clients, including exclusive insights from CIOs and CXOs. Let us know your thoughts.Copyright © 2017 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.JANUARY - 2017Mailing AddressValleyMedia Inc.44790 S. Grimmer Blvd Suite 202, Fremont, CA 94538T:510 230 0396, F:510-894-8405 January - 2017, Vol 03 - 01 Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Editor-in-ChiefStacey SmithEditorial StaffSalesVisualizerStephen ThomasAaron Pierce Alex D'SouzaAva GarciaJenna VegasJoshua ParkerJoe PhilipPharma Analytics Richard Rodriguez richard@pharmatechoutlook.comEditorialStacey Smith Editor-in-ChiefPharma Tech OutlookUnearthing New Possibilities TECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >